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Hypertrophic Response in Primary Single-Cell Culture 
of Adult Rat Myocardial Cells 
Phillip Chung-Ming Yang 
1989 
We have devised a method to reliably isolate and culture 
adult rat heart cells. The average yield of 10 million total 
cells and approximately 70% viability have been consistently 
reproduced. (Rod-shaped criterion has been used to determine the 
viability.) The viable cells are cultured for 8 days at which 
time they undergo morphological changes into flat astrocyte-like 
configuration with multiple pseudopods. Primary culture of 
approximately 80% adult rat heart myocardial cells (MC) 
maintained in single layer and low density is obtained. We asked 
whether hypertrophy could be induced in the MC through the 
addition of the following agents: 1.) Norepinephrine (NE), 2.) NE 
and Propranolol (PRO), 3.) Phorbol ester (TPA:tumor promoting 
agent), and 4.) 5% Calf-serum (CS) The cell cultures were 
maintained in minimum essential media plus 1% CS for 6 days and 
minimum essential media plus transferrin and insulin (CS-free) 
for the remaining 2 days. By the end of incubation period, the 
myocardial cells had weld differentiated and showed no sign of 
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proliferation. At this time, we brought the culture medium to 
O.luCi/ml with (u-14C) phenylalanine and added the following 
agents: 1.) Diluent (control), 2.) NE (0.2uM), 3.) NE (0.2uM) and 
PRO (0.2uM), 4.) TPA (O.luM), and 5.) 5% CS. Following the 
incubaton period of 48 hours, we determined the extent of 
hypertrophy by measuring the increase in cell protein content 
using the radioisotopic method (scintillation count). 
The results were the following: 1.) NE increased cell size by 
1.15 fold, 2.) NE + PRO increased by 1.24 fold, 3.) TPA increased 
by 1.2 fold, and 4.) CS increased by 1.5 fold (p<0.01). While the 
level of response is not as large as in neonatal rats as previous 
studies have shown, this finding indicates that the adult rat MC 
possess the similar capability to undergo hypertrophy through 
alphal-adrenergic receptors. Furthermore, the addition of a beta 
adrenergic receptor antagonist, propranolol, has enhanced the 




Primary cultures of adult rat myocardial cells (MC) have 
been an extremely important model to enhance our understanding of 
cardiac cell structure and function (1) Many investigators have 
reported various techniques to improve the methods of 
dissociating adult rat MC and of preparing single-cell primary 
cultures (1,2,3,4,5,6). A definitive method, however, to reliably 
isolate and culture adult rat MC has been difficult to develop 
(1,2). 
We have developed an inexpensive and simple method that 
reliably isolates and cultures adult rat MC. Our model 
consistently isolates 10 million total cells with 70% viability 
(rod-shaped criterion) and provides a cell culture which at the 
end of the incubation period (8 days) shows all of the 
following: MC predominance (>80%) in a single cell layer and low 
density, a well differentiated cellular morphology (flat 
astrocyte-like configuration with multiple pseudopods), 
and lack of MC proliferation. Such primary cell culture system 
is critical in order to isolate and study a single physiological 
phenomenon. The model allows the control of all the variables by 
eliminating numerous stimuli that are present in vivo. It allows 
the testing of a single factor in a systematic fashion. 
Limiatations, however, also exist. The experimental environment 
is artificial. Important factors such as 1.) cell-cell 
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interactions are altered since each cell is isolated in a low 
density culture, 2.) cellular morphology changes as each cell 
adapts to the culture substrate, and 3.) culture medium is 
different from tissue fluid. Nevertheless, a single cell-culture 
system allows the investigation of a single physiological 
phenomenon at a fundamental cellular level 
One interesting area where single cell culture system could 
be used effectively is in the study of myocardial hypertrophy. 
Myocardial hypertrophy has long been recognized both as an 
adaptive and a pathological response to cardiovascular needs (7). 
Hypertrophy plays a critical role in normal development and in 
response to exercise (7). Yet, hypertrophy has also been 
associated with congestive heart failure, hypertrophic 
cardiomyopathy, valvular diseases, and hypertension (8,9,10). So, 
is physiologic hypertrophy different from pathologic hypertrophy? 
If so, is hypertrophy an adaptive response to or an etiology of 
cardiovascular pathologies? In order to address these critcally 
important issues, a fundamental understanding of the mechanism of 
myocardial hypertrophy needs to be elucidated first. 
The heart undergoes hyperplasia throughout the fetal life 
of both the rats and human beings. It continues to grow in a 
similar fashion during the first four weeks of a neo-natal rat 
and during the first three months of a newborn human baby 
(11,12). After this developmental period, cardiac growth becomes 
entirely dependent on hypertrophy as it reaches the normal size 
of an adult heart (8). Physiologic hypertrophy is this process of 
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increase in cardiac muscle mass (ventricular diameter and wall 
thickness) resulting from the addition of contractile proteins 
while the population of myocardial cells remains constant (13). 
It is physiologic since the increase in cardiac muscle mass 
translates to elevated contractile function necessary for normal 
development (14). The primary stimuli for this physiologic 
hypertrophy appears to be the hemodynamic variables (8). However, 
studies have suggested that the critical 1 ink between hemodynamic 
stresses and cardiac hypertrophy may be hormonal (15). The 
collected data have indicated that norepinephrine may play a 
significant role in induction of myocardial growth (15). In 
another study, chronic administration of subhypertensive dose of 
norepinephrine led to significant ventricular hypertrophy (16). 
While the hemodynamic stresses and the subsequent hormonal 
release appear to induce hypertrophy, more questions remain: 1.) 
what is the exact cellular mechanism leading to hypertrophy and 
2.) are there other agents besides norepinephrine that induce 
hypertrophy? 
There have been three major approaches to answer the 
questions. First of all, protein synthesis has been studied. One 
of the requirements for cardiac hypertrophy is that the rate of 
protein synthesis must exceed the rate of degradation (17). Data 
have been collected which suggest that the increased aortic 
pressure and the attendant stretch of the heart muscle are 
closely associated with the faster rates of protein 
synthesis(17). As to how the mechanical parameters translate to 
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increased protein synthesis is not clearly known. One postulate 
has involved the regulation of the synthesis of myosin iso¬ 
enzymes (18). There are three myosin iso-enzymes: VI myosin- 
homodimer of 2 alpha heavy chains, V2 myosin - heterodimer of 1 
alpha and 1 beta heavy chains, V3 myosin - homodimer of 2 beta 
heavy chains (18). Studies have correlated well-documented 
phenomenon of thyroid hormone-induced myocardial hypertrophy with 
the accumulation of alpha heavy chain mRNA and concomitant loss 
of beta heavy chain mRNA (12). Furthermore, the relative 
synthetic rates of alpha and beta heavy chains have been reported 
to reflect the proportion of their respective mRNA's present 
(12). On a molecular level, this implies that the regulation of 
protein synthesis may precede the translation of the message 
(12). Finally, a different study has provided a similar set of 
data that shows a rapid shift from one isoform of myosin mRNA to 
another isoform following aortic stenosis (19). Thus, an 
intricate regulation of protein synthesis at pre-translational 
level appear to respond to trophic stimuli inducing hypertrophy. 
The second approach has involved the renin-angiotensin (R-A) 
system. A study has shown that the R-A system along with 
catecholamines play a role in cardiac hypertrophy (20). 
Furthermore in the same study, activation of the sis proto¬ 
oncogene has been detected in myocardial cells undergoing 
hypertrophy (20). This raises a possible similarity between the 




Finally, our approach in the laboratory has been to study 
the role of alphal-adrenergic receptor and its response to 
norepinephrine stimulation. Studies with the primary culture of 
neonatal rat myocardial cells (MC) have shown that when the MC 
are stimulated by norepinephrine, they undergo 1.5 to 2.0 fold 
increase in cell size and produce spontaneous contraction in 
essentially all of the cells (2]). Hypertrophy and contractile 
activity have been found to be mediated through alphal-adrenergic 
receptor (22). Nevertheless, the alphal-adrenergic receptor 
mediated responses differ significantly in two major respects. 
First of all, hypertrophy only requires alphal stimulation while 
contractile activity requires both alphal and beta activations 
(23). This means that myocardial cells stimulated through alphal 
receptor can undergo hypertrophy without contractile activity. A 
similar observation of hypertrophy without contractile activity 
has been made when neonatal rat MC were stimulated with phorbol 
esters or with norepinephrine in the presence of calcium-channel 
antagonists (24,25). 
The second major difference between the two alphal mediated 
responses is that hypertrophy requires RNA and protein synthesis 
while contractile activity does not. (26). Alphal mediated 
hypertrophic response was blocked by inhibition of protein 
synthesis with cyclohexamide or by inhibition of RNA synthesis 
with actinomycin D (26). The contractile activity, however, 
persisted despite the addtion of cyclohexamide or actinomycin D 
(26). These observations suggest dual functions of alphal- 
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adrenergic receptor and a possibility of two seperate 
intracelluar pathways mediated by alphal-adrenergic receptor. 
The above findings regarding the role of alphal-adrenergic 
receptors have been made using the neonatal rat primary culture 
system. In this study, we asked whether norepinephrine could 
similarly induce hypertrophy in adult rat myocardial cells. The 
investigation was divided into three major stages. The first 
stage comprised of isolating viable myocardial cells. We devised 
a simple and reliable method which consistently produced a yield 
of 10 million cells with approximately 70% viability. The second 
stage involved the maintenance of adult rat MC in long-term 
primary culture. At the end of 8 day incubation period, we were 
able to develop single-layer, low density culture of 
approximately 80% MC predominance, a well-differentiated cellular 
morphology, and lack of MC predominance. The third stage entailed 
the testing of the trophic response of adult rat MC to the 
following agents: 1.) Diluent (control), 2.) Norepinephrine (NE), 
3.) NE + Propranolol (PRO), 4.) Phorbol Ester (TPA:tumor 
promoting agent), and 5.) 5% CS. Our data indicate that a 
significant hypertrophic response (p<0.01) was seen with the 
addition of all four agents. The hypertrophic response to NE was 
further enhanced when the beta-receptor was blocked with the 
addition of PRO. This finding suggests that the alphal-receptor 
plays a key role in inducing hypertrophy while the beta- 
receptor acts to inhibit hypertrophy. 
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MATERIALS AND METHODS 
The experiment has been divided into three major stages: 
I. Isolation of single adult rat myocardial cells (MC) 
II. Maintenance of MC in long-term primary culture 
III. Stimulation of the MC to test hypertrophic response with the 
following agents: 1.) Diluent (control). 2.)Norepinephrine 
(NE), 3.) NE + Propranolol (PRO), 4.) Phorbol Ester 
(TPA:tumor promoting agent), and 5.) 5% Calf-serum (CS). 
Material 
Male Sprague-Dawley rats weighing 250~300g. and 
approximately 3-4 months old were used. Reagents used in this 
experiment were obtained from the following sources: collagenase 
CLS II, 143 U/mg, lot #45M7903 (Cooper Biomedical); bovine serum 
albumin, lot#73F-9305 (Sigma); calf-serum (Sterile System); 
Minimum Essential Media Eagle with Hanks BSS with glutamine, with 
0.35 GRA/LT NaHC03 #671 (UCSF Cell Culture Facility); (u-14C) 
phenylalanine, SWO #225316 (ICN); heparin sodium (Invenex); 
arabinoside cytosine #C-6645 (Sigma); percoll #P-1644 (Sigma); 
aquasol (New England Nuclear); and all of the following came from 
Sigma: ether, trichloroacetic acid, sodium dodecyl sulfate, 
phosphate-buffered solution, streptomycin sulfate, transferrin, 
insulin, norepinephrine, propranolol, and phorbol ester. 
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Perfusion Solution and Culture Media 
The following solutions were prepared: 
Hepes buffer solution: NaCl, 115mM; KC1, 5.36mM; MgS04+7H20, 
0.81mM; dextrose, 27.5mM; KH2P04+7H20, 0.34mM; Na2HP04+7H20, 
0.34mM; Hepes, 20mM, (pH=7.4); lactate, 1.5mM; pyruvate, 2.0mM; 
penicillin, 50U/ml; and streptomycin, SOug/ml. The solution was 
adjusted to pH=7.3 and sterilized by filtration through a 
Millipore Filter (pore size=0.45um). 
Enzyme solution: collagenase, 1.5mg/ml; bovine serum albumin, 1 
mg/ml; and buffer solution, 80ml. 
Perfusion solution: heparin sodium, 1ml; and buffer solution, 
200ml. 
Di ssociation solution: calf-serum, 2%; and buffer solution, 
100ml. 
Percoll solution: Isotonic percoll solution, 40% volume in 
isotonic Hepes-buffer solution. 
Growth medium: Minimum essential media; CS, 10%; penicillin, 
50U/ml; and Vitamin B12, 1.5uM. 
Serum-free medium: Minimum essential media; transferrin, lOug/ml; 
insulin, lOug/ml; penicillin, 50U/ml; and Vitamin B12, 1.5uM. 
Laminin solution: Minimum essential media; laminin, lOug/ml; 
penicillin, 50u/ml; and Vitamin B12, 1.5uM. 
Stage I: Isolation of Single Adult Rat Myocardial Cells (MC) 
Anaesthesia of the rat: Three anaesthetic agents were tested. 
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Methoxyflurane induced severe hypoxemia, hypercarbia, and 
acidosis based on ABG obtained directly from the heart at the 
time of sedation suggesting significant ventilatory suppression. 
Pentobarbital produced prominent myocardial infarcts. Ether was 
the most effective agent producing minimal respiratory and 
cardiac suppression. Ether is now routinely used. 
Sex of the animal: When the cell yields and viability are 
corrected for body weight, we found that there was no significant 
difference between male and female rats. The mean cell yields for 
female rats were 33.5+9.3 million cells/kg body weight and those 
for males were 36.3+^10.4 million cells/kg body weight. The mean 
percentage of viable rod shape MC for both sexes was 70+6%. 
Cell isolation technique: The rats were injected with heparin 
sodium, 0.75ml, at least 20 minutes prior to the excision of the 
heart. The heart was then quickly removed from the rat and 
immersed in a calcium-free isotonic perfusion solution maintained 
at 4 degrees celcius. The heart was then immediately mounted to a 
large 13-gauge Eppendorf tip attached to a Langendorf perfusion 
apparatus. The mounting is a critical step (<3 minutes) since the 
Eppendorf tip could be easily advanced too far into the left 
ventricle preventing the proper perfusion of the coronary 
circulation or damaging the aortic valve. Langendorf perfusion 
was then performed using the perfusion solution (calcium-free and 
contains 1000U heparin) during the first four minutes. The 
perfusion was performed using gravity from the height of 81.6cm 
(equivalent to 60mmHg). During this time the heart was 
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essentiallly washed to remove blood and extracellular calcium. 
This was then followed by enzyme (collagenase) solution perfusion 
at a slow, constant flow rate of 1.5ml/min maintained by a 
peristaltic pump for 40-50 minutes. During the enzyme solution 
perfusion, the heart was completely immersed in a perfusion 
solution maintained at 37 degrees celcius. In addition, 85% 
oxygen and 15% nitrogen mixture gas was being constantly bubbled 
into both enzyme and perfusion solutions. The heart should remain 
uniformly pink throughout the procedure and should not show any 
spontaneous contraction. 
Following the enzyme solution perfusion period, the heart 
was placed into a 37 degrees celcius perfusion solution that also 
contains 0.5mM CaC12. The intact heart was then able to be gently 
pulled apart using a pair of tweezers and a scalpel. The heart 
pieces were transferred into 8ml of enzyme solution which also 
contains 0.5mM CaC12. This suspension was gently shaken for 10 
minutes in water bath maintained at 37 degrees celcius to 
dissociate the heart into single MC. The supernatant which 
contains the single MC was decanted to be saved and additional 
8ml of enzyme solution was added to the intact heart pieces. This 
dissociation procedure was repeated for a total of three times. 
After letting the supernatant settle by gravity for twenty 
minutes following the last dissociation, a pellet of MC formed at 
the bottom of the tube. The supernatant was decanted and the 
pellet of MC was resuspended in growth medium and allowed again 
to settle by gravity for 20 minutes. Following this period, the 
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supernatant was decanted and the MC pellet was added to a tube 
containing percoll solution. The percoll solution containing the 
MC pellet was centrifuged at 29g for 5 minutes. Viable MC settle 
at the bottom of the tube while the dead, rounded MC and other 
non-MC formed a distinct layer on the top which was easily 
decanted. This percoll seperation step was repeated and the final 
MC pellet was resuspended in growth medium. Cell count was then 
performed on an eosinophil counting chamber using the rod-shape 
criterion to count the viable MC. 
Stage II: Maintenance of MC in Long-term Primary Culture 
For long-term culture of adult cardiac myocytes, care must 
be taken to minimize contamination during the isolation 
procedure. After isolation of the cells, all tubings needed to be 
rinsed with 10% bleach, then with sterile distilled water and 
again soaked in distilled water overnight. They were then air 
dried and kept under UV light until use. Collagenase solution 
should be filtered with a 0.22um filter. All buffer solutions 
contain penicillin and streptomycin. The growth and serum-free 
media contain penicillin. 
Cell Culture 
The 35mm Corning dishes were used to plate the cells. Each 
dish was coated with 1ml of laminin solution for at least 12 
hours prior to plating the cells. Laminin promotes initial 
adherence of the MC to culture dishes at an impressive number and 
facilitates the cellular transformation into a flat, star-like 
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configuration with long-term survival in culture (41,42). At the 
end of the laminin coating, the solution was removed from the 
dishes. 
Two ml of the uniform suspension of MC were plated on 
laminin-coated 35mm Corning dishes and incubated for 1 hour. The 
plating density of the MC was set at 200 cells/mm2. At the end 
of the incubation period, the growth medium was aspirated to 
remove the unattached cells and newly made growth medium with 10 
uM cytosine arabinoside and lOuM gentamycin was added. On culture 
day 3, the growth medium was changed with freshly prepared growth 
medium containing lOuM cytosine arabinoside. On culture day 6, 
the growth medium was replaced with serum-free medium for 2 days. 
In order to measure the hypertrophic effects of the various 
trophic agents, 0.1 uCi of (u-14C) phenylalanine was added to 
newly made serum-free medium to prepare a radiolabeling solution 
(21,43). On culture day 8, the 2 day old serum-free medium was 
replaced by the radioisotopic medium. Several hours later, the 
following agents were added for 48 hours to the cell-culture 
dishes of the respective group: 1.) diluents (control), 2.) 0.2uM 
Norepinephrine (NE), 3.) 0.2uM NE + 0.2uM Propranolol (PRO), 4.) 
0.luM Phorbol ester (TPA: tumor promoting agent), and 5.) 5% 
Calf-serum (CS). The protein content of each cell culture was 
determined 48 hours later by scintillation count method (23). The 
protein degradation of NE was prevented by the addition of lOOuM 
Vitamin C to the NE solution and also by the maintenance of the 




The cells were counted in 17 randomly selected fields 
throughout the entire dish (44). Each field was equivalent to 
0.96mm2 surface area. We, therefore, counted 2% of the total 
800mm2 surface area of the dish. In order to measure the number 
of cells per dish, the following calculation was performed: 
# of cells/dish= (cells/f ield)x (1.006x.field/mm2 ) x ( 800mm2/di sh) . 
The number of MC was counted for each dish. 
Stage III: Stimulation of the MC to Test Hypertrophic Response 
Cell size was measured by quanitifying the total cell 
protein concentration. Since the cells do not divide, the 
increase in dish protein indicated the increase in cell size or 
hypertrophy. The total protein content was measured by using 
asymptotic labelling with a radioactive amino acid (23). Using 
(u-14C) phenylalanine, the culture medium was brought up to 
O.luCi/ml. Phenylalanine ws used since the amino acid is not 
metabolized by myocardial tissue (23). After incubating the cell 
culture with radioisotopic medium and with the trophic agents for 
48 hours: 1.) Diluent (control), 2.) NE, 3.) NE+PRO, 4.) TPA, and 
5.) 5% CS, 14C-phenylalanine incorporation was measured by 
scintillation count. The scintillation count. for each dish was 
divided by the number of MC per dish to measure the protein 
concentration per cell. 
The cell protein defined as material that was 
trichloroacetic acid (TCA)-insoluble and sodium dodecyl sulfate 
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(SDS)-soluble was quantified by liquid scintillation counting 
(23). On culture day 10, the radioisotopic labelling medium was 
removed, the attached MC was rinsed with phosphate buffered 
saline (PBS) and treated with 10% TCA at 0 degree celcius for at 
least 1 hour. Then the MC was rinsed with TCA three times and 
dissolved in 1ml of 1% SDS overnight. The entire SDS solution was 
transferred into plastic vial with 5ml of Aquasol and was 
counted. 
Statistical Analysis 
All data were presented as mean + SE. For comparison. 
Student's t-test for unpaired and paired observations was used. A 
p-value<0.05 was considered a statistically significant 




General Characteristics of Adult Rat Heart Single-Cell Cultures 
The dissociation method yielded an average of 10 million 
cells per heart with approximately 70% viable rod-shaped 
myocardial cells (MC). The initial attachment of the cells to the 
culture dishes consisted predominantly of MC (>80%). The 
morphology of MC was initially marked by the characteristic rod- 
shape, cross-striated cytoarchitecture, and contractility (Fig. 
1). On culture day 2, the cells became round-shaped. By culture 
day 3, the cross-striations disappeared and the MC started to 
flatten out at each end of the cell. By day 6, the initial 
morphology completely changed into a flat cellular appearance 
with translucent cytoplasm and developed multiple, slender 
pseudopods growing in all directions (Fig.2). Throughout the 
course of cellular development, the MC did not proliferate. 
Instead, the cell culture showed attrition in the number of MC. 
Hypertrophic Response 
Hypertrophy was quantified through an increase in the cell 
protein content using the 14C-phenylalanine incorporation 
technique measured by the scintillation counting method. HC1- 
and DMSO-treated (diluent for NE, PRO, and TPA) MC served as a 
control (Fig.3). The difference in the hypertrophic response 
between the testing agents-treated (NE, NE+PRO, TPA, & CS) and 
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the control-treated MC was described as % of the control. Control 
was set at 100%. All the data were obtained from 8 experiments 
with each experiment consisting of 30 culture dishes with 6 
dishes in each respective group: 1.) Control (diluent), 2.) NE, 
3.) NE+PRO, 4.) TPA, and 5.) 5% CS. 
NE-treated MC showed a significant increase in the cell 
protein content. The increase of 14C-phenylalanine incorporation 
of NE-treated MC averaged 115%+4.9 (p<0.01) of the control (Fig.4 
& 8) . 
NE+PRO-treated MC also showed a significant increase in the 
cell protein content. The increase of 14C-phenylalanine 
incorporation of NE+PRO-treated MC averaged 124%+4.3 (p<0.01) of 
the control (Fig.5 & 8). 
TPA-treated MC similarly showed a significant increase in 
the cell protein content. The increase of 14C-phenylalanine 
incorporation of TPA-treated MC averaged 120%+4.9 (p<0.01) of the 
control (Fig.6 & 8). 
Five percent CS-treated MC showed the largest increasae in 
the cell protein content. The increase of 14C-phenylalanine 
incorporation of 5% CS-treated MC averaged 159%+6.7 (p<0.01) of 
the control (Fig.7 & 8). 
In addition, the NE+PRO-treated MC showed significant 
increase in the cell protein content when compared to the NE- 
treated MC. The 14C-phenylalanine incorporation of NE+PRO-treated 





We succeeded in devising a simple and reliable method to 
prepare single-cell culture of adult rat heart. We consistently 
produced a yield of 10 million cells with approximately 70% 
viability. The time required for preparation was 6-7 hours and 
the amount of viable myocardial cells (MC) was quantitatively 
sufficient to conduct our experiment. We believe that our model 
provides an acceptable system to study the cell biology of the 
adult rat heart (1,6,8,30). 
Our method improved several important areas of adult rat 
heart single-cell preparation. First of all, we examined two 
critical parameters of the dissociation (Stage I) of adult rat 
heart into single MC: enzyme perfusion rate and maintenance of 
the temperature of the heart. The first variable involved the 
enzyme perfusion rate. The normal diastolic blood pressure of the 
rat is between 58-145mmHg. In theory, a good retrograde perfusion 
requires a physiological pressure of at least 60mmHg. However, a 
60mmHg pressure delivers a high flow rate of approximately 
14jf4ml/min which would require large volume of the collagenase 
solution or necessitate the enzyme to be recirculated. The large 
volume of the collagenase solution would be economically 
prohibitive and the recirculation of the solution would introduce 
many intracellular substances that may damage the viable cells. 
Furthermore, the perfusion pressure set at 60mmHg may induce 
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vasoconstriction of the coronary vessels interfering with the 
perfusion process. We, therefore, opted to select a constant flow 
rather than constant pressure technique to perfuse the heart. 
Different flow rates have been carefully examined. Under 
identical conditions, the most effective flow was the one that 
will consistently offer the highest cel], yields with the 
greatest fraction of viable cells. We have found that a flow rate 
of 1.5ml/min (maintained constant by peristaltic pump) repeatedly 
achieved this objective. This slow flow rate had many advantages: 
1. ) It allowed maximal time of exposure to the collagenase 
without any additional damage done to the MC due to the 
perfusion pressure. 
2. ) Gas analysis indicated that the oxygen tension and 
saturation of the enzyme solution obtained after perfusion is 
sufficiently adequate to oxygenate the MC. 
3. ) Air embolism, when occured, could not cause any damage to 
the heart at such slow flow rate. The embolus is slowly pushed 
out of the coronary circulation and no infarct occurs. This 
phenomenon has been observed numerous times. 
4. ) The slow flow rate allows a prolonged perfusion with a 
small volume of collagenase without requiring its 
recirculation. 
Secondly, we devised a method to maintain the ambient 
temperature of the heart during the enzyme solution perfusion at 
37 degrees celcius. This was accomplished by totally immersing 
the heart into a double-jacket chamber that contains the Hepes- 
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buffer solution and maintained at 37 degrees celcius. This 
chamber is drained at the same rate as the enzyme perfusion flow 
rate. The enzyme solution was also maintained at 37 degrees 
celcius. 
We, furthermore, examined two parameters to improve the 
technique of maintaining the long-term culture of single MC 
(Stage II). Two modifications were critical in order to sustain 
a viable long-term primary culture: elimination of non-myocardial 
cells and reduction of cell death after its attachment to the 
dish. First of all, when establishing a long-term culture of MC 
in the presence of calf-serum, proliferation of non-MC such as 
fibroblasts, endothelial cells, smooth muscle cells, neurons, 
macrophages, lymphocytes, and other blood-born cells presents a 
major problem. We eliminated this unnnecessary growth of non-MC 
by two steps: 
1. ) Density sedimentation using Percoll solution before plating 
seperated the isolated, small size non-myocytes. 
2. ) The adult rat MC do not undergo mitosis while the non-MC do 
profliferate rapidly in the presence of the calf-serum. The use 
of potent anti-mitotic agent such as cytosine arabinoside at 
lOuM effectively reduced the percentage of non-MC to <10%. 
Secondly, the rate of cell death following their attachment 
to the culture dishes and during the 6 days of culture needed to 
be reduced. The viability of the MC during the long-term culture 
was improved by the following measures: 
1.) Supplementation of the culture medium with 1% calf-serum 
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significantly improved the attrition rate of viable MC during 
the 6 days of culture. The unnecessary proliferation of non-MC 
as mentioned above was eliminated by the addition of lOuM 
cytosine arabinoside. 
2.) On culture day 3 and 6, the culture dishes were rinsed to 
remove the non-attached round cells presumed to be dead and the 
growth medium was also replaced. Th.i s left behind a highly 
purified culture of predominantly viable MC. 
Hypertrophic Response 
Using this system, we studied the possible hypertrophic 
effect of different agents on adult rat MC. Previous studies have 
shown that hypertrophy of neonatal rat heart cells is stimulated 
by NE through alphal adrenergic receptors (21,43). We similarly 
have determined that NE induce hypertrophy in adult rat MC. 
However, the hypertrophic response appears markedly reduced in 
adult rat heart MC. While the exact etiology is not known, this 
phenomenon may be possibly correlated with a well-established 
peculiarity of adult rat MC which is known to have shortened 
action potential (18). Another postulate may be that the alphal- 
mediated hypertrophy might be an early developmental response 
that is only fully re-expressed in the adult by an alternative 
stimulus such as the thyroid hormone (12). Furthermore, the adult 
rat MC essentially are matured MC (6). The matured MC may no 
longer have any physiological need to increase its size. Thus, 
the alphal receptors may have developed to mediate other cellular 
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mechanisms that have become increasingly important during growth 
such as contractile activity (26). Finally, it is also possible 
that the alphal adrenergic receptors may have been down- 
regulated and the intracellular mechanism involved in hypertrophy 
may have lost its efficacy. These hypotheses, however, require 
further investigations. 
The enhanced hypertrophic response seen when propranolol was 
added to norepinephrine suggests a possible inhibitory effect of 
beta-adrenergic receptors in hypertrophy. Although the mechanism 
of the beta receptors' involvement in hypertrophy is hardly 
known, based purely on our experimental observation, it is 
possible to propose a certain antagonistic effects of beta- 
mediated response to hypertrophy. One hypothesis may be related 
to the phenomenon in which contractile activity requires both 
alphal- and beta-receptors (26). It is possible that the 
hypertrophic and contractile responses share a similar 
intracellular pathway. The simultaneous stimulation of alphal- 
and beta-receptors by NE may preferentially stimulate the 
contractile activity and thus, reducing the efficacy of 
hypertrophy which is purely an alphal-mediated response (22). 
By adding propranolol, a beta-anatagonist. the inhibitory effect 
of beta-receptor to hypertrophy may have been reduced. 
In the case of TPA-treated MC, it has been suggested that 
the TPA-induced hypertrophy might serve as model for pathological 
hypertrophy (31). Studies have shown that the TPA-treated MC that 
undergo hypertrophy have reduced contractile protein content when 

compared to the NE-treated counterpart (31). While the mechanism 
of hypertrophy is unclear, the effect of TPA to increase overall 
cell size without an increase in contractile protein provide a 
possible explanation for pathological hypertrophy (31). In vivo, 
cells from pathologically hypertrophied hearts (decompensated 
aortic stenosis) show a selective reduction in the volume 
fraction of myofibrils (32). 
Finally, the cells that were treated with 5% CS showed the 
highest hypertrophic response. This result attests to the 
enormous complexity of hypertrophy which responds best to the 
multiple growth factors that are present in the calf-serum. It 
also reinforces the difficulty of isolating one dominant humoral 
agent that might be responsible for hypertrophic response. It 
appears most likely that numerous trophic agents work singly or 
in conjunction with other agents to induce hypertrophy in 
response to different physiological circumstances such as normal 
growth, exercise, hypertension, cardiomyopathy, etc. All these 
conditions place unique hemodynamic demands to the heart probably 
triggering different factors in each circumstance. 
While the data from our experiment provide a new insight to 
the phenomenon of hypertrophy in adult rat MC, the subsequent 
discussion and explanation for the results are primarily 
hypothetical. In order to better understand the phenomenon of 
alphal-stimulated hypertrophy of adult rat MC, .it is critical to 
elucidate the intracellular mechanism. Although the intracellular 
pathway of adult rat MC is currently investigated, some studies 
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have already shown the mechanism involved in the alphal-mediated 
hypertrophy of neonatal rat MC. 
Intracellular Mechanism 
There have been two approaches to study the intracellular 
mechanisms involved in alphal-stimulated hypertrophy of neonatal 
rat MC: 1.) genetic expression in alphal-stimulated hypertrophy 
and 2.) intracellular pathway leading to the induction of gene 
expression. First of all, studies have looked at the mRNA and 
protein expression of c-myc proto-oncogene, actin, and myosin. 
It has been shown that alphal stimulation induces transient 
increase in c-myc proto-oncogene mRNA (34). Recent studies have 
also associated the c-myc mRNA with cell proliferation (34). This 
may imply common intracellular mechanism between cell 
proliferation and hypertrophy. Another area of investigation 
looked at the expression of actin and myosin mRNA isoforms during 
MC hypertrophy. It has been shown that the alphal-mediated 
hypertrophy induces an increase in the expression of actin and 
myosin mRNA isoforms that are prevalent in immature, growing 
heart (35). The studies suggest alphal-stimulated hypertrophy may 
be associated with expression of growth and developmental genes 
(35) . Furthermore, another study has shown that during pressure¬ 
load hypertrophy of the adult rat heart in vivo, there is also an 
increased expression of a similar immature isoform of actin mRNA 
(36) . These studies suggest the possibility of an increased 
expression of the developmental mRNA isofrom in both alphal- 
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mediated and pathological hypertrophy. 
The second approach to elucidate the mechanism of alphal- 
mediated hypertrophy involved the intracellular pathways that are 
activated by the alphal receptors to induce gene expression. The 
primary intracellular event following the activation of alphal- 
adrenergic receptor is a hydrolysis of phosphatidylinositol-4,5- 
biphosphate (PI) in the plasma membrane to produce two 
intracellular messengers: myo-inositol-1,4,5-triphosphate (IP3) 
and 1,2-diacylglycerol (DAG) (37). IP3 activates the release of 
the calcium from endoplasmic reticulum which then binds to the 
regulatory protein, calmodulin (37). DAG activates protein kinase 
C which subsequently phosphorylates and alters the cellular 
proteins (37). Studies have been made to determine the level of 
PI hydrolysis by measuring IP3 and PKC in neonatal rat MC 
following alphal-stimulation (38,39). The levels of both IP3 and 
PKC productions have been seen to increase following alphal 
stimulation (38,39). These findings suggest a possible role of 
PI, IP3, and PKC in mediating the alphal-stimulated hypertrophy. 
Conclusion 
We were able to provide new information regarding the 
alphal-mediated hypertrophy in adult rat MC. We found that the 
adult rat MC respond to lesser magnitude than the neonatal rat MC 
to the trophic factors. Some type of physiologic adaptation of 
the alphal mechanism must exist from neonatal to adult rat to 
reduce the adult rat MC's potential to hypertrophy (40). In order 
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to explain such phenomenon, the intracellular pathway of 
hypertrophy of adult rat MC need to be studied to answer the 
following questions: 1.) do the intracellular events change as 
the rat ages and 2.) do the alpal receptors themselves undergo 
morphologic changes? Finally, the over-riding concern is how do 
all these cellular and molecular biology ultimately translate to 
in vivo in human beings. While the answers can not be obtained 
immediately, it is of utmost importance to at least comprehend 
the phenomenon of cardiac hypertrophy at the most fundamental 
levels before any medical application is achieved. 
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Figure 1. Photograph of adult rat MC immediately following the 
diassociation. The morphology of MC is marked by the 
characteristic rod-shape, cross-striated 







Figure 2. The photograph of adult rat MC on culture day 6. The 
morphology of the MC is marked by its flat cellular 
appearance with translucent cytoplasm and well- 




Figure 3 . The photograph of adult rat MC on culture day 10 
following 2 days of diluent-treatment (control). 
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Figure 4. The photograph of adult rat MC on culture day 10 
following 2 days of NE-treatment. The increased 
cell size is readily apparent in comparison to the 
control MC. 

Figure 5. The photograph of adult rat MC on culture day 10 
following 2 days of NE+PRO-treatment. The increase 
in cell size is readily apparent when compared to 




Figure 6. The photograph of adult rat MC on culture day 10 
following 2 days of TPA-treatment. The increase in 
cell size is readily apparent when compared to the 
control MC. A close observation shows increased 
granularity within the cytoplasm which may possibly be 




Figure 7. The photograph of adult rat MC on culture day 10 
following 2 days of 5% CS-treatment. The increased 
cell size is readily apparent when compared to all 
the other MC. In addition, the CS-treated MC appear 







Figure 8 Hypertrophy Measured Through 14C-Phenyialanine 
Incorporation by MC. 
The control was set at 100%. The NE, NE+PRO, TPA, and 
5% CS treated MC were comparedto the control MC. The 
differences were described as % of control. Ail test agents 
significantly induced hypertrophy (p 0.01). The data were 
obtained from 8 experiments with each experiment consisting 
of 30 culture dishes with 6 dishes in each condition. 
Control: 100%. NE; 113-4.9 NE+PRO: 124-4.0 
TPA: 120-4.9 5% CS: 159-6.7 
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Figure 9 Comparison of Hypertrophy Induced by 
NE vs. NE*PRO 
Hypertrophy was measured through 14 C- 
phenylalanine incorporation by MC. NE was set as 
control at 100%. The effect of NE+PR0 was described 
as % of control. NE-PRO induced significant mcreasae 
in hypertrophy when compared to NE alone ip 0.05). 
The data are from 6 experiments with each experiment 
consisting of 6 dishes in each condition, 
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